| Literature DB >> 35855423 |
Sylvia Nabukenya1, Stephen Okoboi1, Vivian Nakate1, Adelline Twimukye1, Bruce Opio1, Barbara Castelnuovo1.
Abstract
Objective: The aim of this study was to explore researchers' experience of using the regulatory affairs information system (RAIS) in strengthening research compliance to national ethics guidelines through tracking ethics and regulatory approvals for research projects at the Infectious Diseases Institute.Entities:
Keywords: information system; regulatory affairs; research compliance
Year: 2022 PMID: 35855423 PMCID: PMC9279882 DOI: 10.1093/jamiaopen/ooac059
Source DB: PubMed Journal: JAMIA Open ISSN: 2574-2531
Figure 1.Regulatory affairs framework of the Infectious Diseases Institute (IDI).
Figure 2.The role of the regulatory affairs information system (RAIS) in compliance to regulatory guidelines.
Characteristics of research participants
| Variable | Frequency |
|---|---|
| Age | |
| <35 years | 14 (38.9) |
| >35 years | 22 (61.1) |
| Sex | |
| Female | 20 (55.6) |
| Male | 16 (44.4) |
| Number of years worked in research field | |
| <10 years | 24 (66.7) |
| 10 years and above | 12 (33.3) |
| Role | |
| Principal investigator | 17 (47.2) |
| Study coordinator | 19 (52.8) |
| Year when staff joined IDI | |
| Before 2015 | 17 (47.2) |
| After 2015 | 19 (52.8) |
| Highest level of education qualification achievement | |
| Bachelor’s degree | 7 (19.4) |
| Master’s degree | 23 (63.9) |
| PhD | 5 (13.9) |
| Other | 1 (2.8) |
| Area of research | |
| Administration | 1 (2.8) |
| Clinical trials | 12 (33.3) |
| Diagnostic | 4 (11.1) |
| Observational studies | 14 (38.9) |
| Other | 5 (13.9) |
| Number of research studies | |
| 5 or less | 17 (47.2) |
| Above 5 studies | 19 (52.8) |
N: number.
Figure 3.Participants’ understanding of regulatory requirements.
Participants understanding of the RAIS functionality
| Frequency | |
|---|---|
| Ever received a notification email from the RAIS reminding you about study’s expiration approval dates | |
| Yes | 28 (90.3) |
| No | 3 (9.7) |
| Estimated number of times ever received a RAIS notification | |
| 3 times and more | 18 (64.3) |
| Less than 3 times | 10 (35.7) |
| Submitted annual reports and requests for renewal of approval 4 weeks prior to expiration dates of RECs, UNCST, or NDA | |
| Yes | 26 (92.9) |
| No | 2 (7.1) |
| RAIS has supported to comply with the regulatory requirements | |
| Agree | 26 (92.9) |
| Neither agree or disagree | 1 (3.55) |
| Disagree | 1 (3.55) |
N: number.
Themes generated from interviews
| Theme | Description |
|---|---|
| Experience | Researchers’ experience of tracking the expiration dates of approvals from the Research ethics committees and regulatory bodies’ before and after the implementation of the RAIS. |
| Benefits | Ways in which RAIS has supported research teams in compliance to national guidelines and institutional policies |
| Shortcomings | Current and foreseeable limitations of the RAIS |